Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Growth 2026-2032
The global Granulocyte-Colony Stimulating Factor (G-CSF) market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Granulocyte-Colony Stimulating Factor (G-CSF) is a hematopoietic growth factor that stimulates the production and release of neutrophils, a type of white blood cell critical for fighting infections. G-CSF exists in both short-acting and long-acting forms, each designed to maintain neutrophil counts in patients with conditions like chemotherapy-induced neutropenia. Short-acting G-CSF, such as filgrastim, requires daily administration due to its rapid clearance from the body. In contrast, long-acting G-CSF, like pegfilgrastim, is modified with polyethylene glycol (PEG) to extend its half-life, allowing for less frequent dosing, typically once per chemotherapy cycle.
United States market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Granulocyte-Colony Stimulating Factor (G-CSF) players cover Amgen, Pfizer, Chugai Pharmaceutical, Tanvex BioPharma, Kashiv BioSciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Granulocyte-Colony Stimulating Factor (G-CSF) Industry Forecast” looks at past sales and reviews total world Granulocyte-Colony Stimulating Factor (G-CSF) sales in 2025, providing a comprehensive analysis by region and market sector of projected Granulocyte-Colony Stimulating Factor (G-CSF) sales for 2026 through 2032. With Granulocyte-Colony Stimulating Factor (G-CSF) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Granulocyte-Colony Stimulating Factor (G-CSF) industry.
This Insight Report provides a comprehensive analysis of the global Granulocyte-Colony Stimulating Factor (G-CSF) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Granulocyte-Colony Stimulating Factor (G-CSF) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Granulocyte-Colony Stimulating Factor (G-CSF) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Granulocyte-Colony Stimulating Factor (G-CSF) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Granulocyte-Colony Stimulating Factor (G-CSF).
This report presents a comprehensive overview, market shares, and growth opportunities of Granulocyte-Colony Stimulating Factor (G-CSF) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Granulocyte-Colony Stimulating Factor (G-CSF) market?
What factors are driving Granulocyte-Colony Stimulating Factor (G-CSF) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Granulocyte-Colony Stimulating Factor (G-CSF) market opportunities vary by end market size?
How does Granulocyte-Colony Stimulating Factor (G-CSF) break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
Granulocyte-Colony Stimulating Factor (G-CSF) is a hematopoietic growth factor that stimulates the production and release of neutrophils, a type of white blood cell critical for fighting infections. G-CSF exists in both short-acting and long-acting forms, each designed to maintain neutrophil counts in patients with conditions like chemotherapy-induced neutropenia. Short-acting G-CSF, such as filgrastim, requires daily administration due to its rapid clearance from the body. In contrast, long-acting G-CSF, like pegfilgrastim, is modified with polyethylene glycol (PEG) to extend its half-life, allowing for less frequent dosing, typically once per chemotherapy cycle.
United States market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Granulocyte-Colony Stimulating Factor (G-CSF) is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Granulocyte-Colony Stimulating Factor (G-CSF) players cover Amgen, Pfizer, Chugai Pharmaceutical, Tanvex BioPharma, Kashiv BioSciences, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Granulocyte-Colony Stimulating Factor (G-CSF) Industry Forecast” looks at past sales and reviews total world Granulocyte-Colony Stimulating Factor (G-CSF) sales in 2025, providing a comprehensive analysis by region and market sector of projected Granulocyte-Colony Stimulating Factor (G-CSF) sales for 2026 through 2032. With Granulocyte-Colony Stimulating Factor (G-CSF) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Granulocyte-Colony Stimulating Factor (G-CSF) industry.
This Insight Report provides a comprehensive analysis of the global Granulocyte-Colony Stimulating Factor (G-CSF) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Granulocyte-Colony Stimulating Factor (G-CSF) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Granulocyte-Colony Stimulating Factor (G-CSF) market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Granulocyte-Colony Stimulating Factor (G-CSF) and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Granulocyte-Colony Stimulating Factor (G-CSF).
This report presents a comprehensive overview, market shares, and growth opportunities of Granulocyte-Colony Stimulating Factor (G-CSF) market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Long-acting G-CSF
- Short-acting G-CSF
- Neutropenia
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amgen
- Pfizer
- Chugai Pharmaceutical
- Tanvex BioPharma
- Kashiv BioSciences
- Sandoz
- Teva
- Mylan
- Coherus BioSciences
- Italfarmaco SpA
- Evive Biotech
- Jiangsu Hengrui Pharmaceuticals
- Amoytop Biotech
- Qilu Pharmaceutical
- CSPC Baike Biopharma
- SL Pharm
- Lunan Pharmaceutical
- Shanghai Sunway Biotech
- Changchun GeneScience Pharmaceutical
- Harbin Pharmaceutical Group
- Hangzhou Jiuyuan Gene Engineering
- Kexing Biopharm
- North China Pharmaceutical
What is the 10-year outlook for the global Granulocyte-Colony Stimulating Factor (G-CSF) market?
What factors are driving Granulocyte-Colony Stimulating Factor (G-CSF) market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Granulocyte-Colony Stimulating Factor (G-CSF) market opportunities vary by end market size?
How does Granulocyte-Colony Stimulating Factor (G-CSF) break out by Type, by Application?
The report requires updating with new data and is sent in 48 hours after order is placed.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Granulocyte-Colony Stimulating Factor (G-CSF) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Granulocyte-Colony Stimulating Factor (G-CSF) by Country/Region, 2021, 2025 & 2032
2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Type
2.2.1 Long-acting G-CSF
2.2.2 Short-acting G-CSF
2.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type
2.2.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Type (2021-2026)
2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Application
2.3.1 Neutropenia
2.3.2 Other
2.3.3 Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application
2.3.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Breakdown Data by Company
3.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales by Company (2021-2026)
3.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Company (2021-2026)
3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue by Company (2021-2026)
3.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Company (2021-2026)
3.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company (2021-2026)
3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Company
3.4 Key Manufacturers Granulocyte-Colony Stimulating Factor (G-CSF) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Granulocyte-Colony Stimulating Factor (G-CSF) Product Location Distribution
3.4.2 Players Granulocyte-Colony Stimulating Factor (G-CSF) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) BY GEOGRAPHIC REGION
4.1 World Historic Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Geographic Region (2021-2026)
4.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country/Region (2021-2026)
4.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
4.4 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
4.5 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
4.6 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
5 AMERICAS
5.1 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
5.1.1 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
5.1.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026)
5.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
5.3 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region
6.1.1 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026)
6.1.2 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2021-2026)
6.2 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
6.3 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) by Country
7.1.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
7.1.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026)
7.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
7.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) by Country
8.1.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026)
8.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
8.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor (G-CSF)
10.3 Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor (G-CSF)
10.4 Industry Chain Structure of Granulocyte-Colony Stimulating Factor (G-CSF)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Granulocyte-Colony Stimulating Factor (G-CSF) Distributors
11.3 Granulocyte-Colony Stimulating Factor (G-CSF) Customer
12 WORLD FORECAST REVIEW FOR GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) BY GEOGRAPHIC REGION
12.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Region
12.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecast by Region (2027-2032)
12.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecast by Type (2027-2032)
12.7 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.1.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.2.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Chugai Pharmaceutical
13.3.1 Chugai Pharmaceutical Company Information
13.3.2 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.3.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chugai Pharmaceutical Main Business Overview
13.3.5 Chugai Pharmaceutical Latest Developments
13.4 Tanvex BioPharma
13.4.1 Tanvex BioPharma Company Information
13.4.2 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.4.3 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Tanvex BioPharma Main Business Overview
13.4.5 Tanvex BioPharma Latest Developments
13.5 Kashiv BioSciences
13.5.1 Kashiv BioSciences Company Information
13.5.2 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.5.3 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kashiv BioSciences Main Business Overview
13.5.5 Kashiv BioSciences Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.6.3 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Teva
13.7.1 Teva Company Information
13.7.2 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.7.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Main Business Overview
13.7.5 Teva Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.8.3 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Coherus BioSciences
13.9.1 Coherus BioSciences Company Information
13.9.2 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.9.3 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Coherus BioSciences Main Business Overview
13.9.5 Coherus BioSciences Latest Developments
13.10 Italfarmaco SpA
13.10.1 Italfarmaco SpA Company Information
13.10.2 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.10.3 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Italfarmaco SpA Main Business Overview
13.10.5 Italfarmaco SpA Latest Developments
13.11 Evive Biotech
13.11.1 Evive Biotech Company Information
13.11.2 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.11.3 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Evive Biotech Main Business Overview
13.11.5 Evive Biotech Latest Developments
13.12 Jiangsu Hengrui Pharmaceuticals
13.12.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.12.2 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.12.3 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.12.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.13 Amoytop Biotech
13.13.1 Amoytop Biotech Company Information
13.13.2 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.13.3 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Amoytop Biotech Main Business Overview
13.13.5 Amoytop Biotech Latest Developments
13.14 Qilu Pharmaceutical
13.14.1 Qilu Pharmaceutical Company Information
13.14.2 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.14.3 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Qilu Pharmaceutical Main Business Overview
13.14.5 Qilu Pharmaceutical Latest Developments
13.15 CSPC Baike Biopharma
13.15.1 CSPC Baike Biopharma Company Information
13.15.2 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.15.3 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 CSPC Baike Biopharma Main Business Overview
13.15.5 CSPC Baike Biopharma Latest Developments
13.16 SL Pharm
13.16.1 SL Pharm Company Information
13.16.2 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.16.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 SL Pharm Main Business Overview
13.16.5 SL Pharm Latest Developments
13.17 Lunan Pharmaceutical
13.17.1 Lunan Pharmaceutical Company Information
13.17.2 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.17.3 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Lunan Pharmaceutical Main Business Overview
13.17.5 Lunan Pharmaceutical Latest Developments
13.18 Shanghai Sunway Biotech
13.18.1 Shanghai Sunway Biotech Company Information
13.18.2 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.18.3 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Shanghai Sunway Biotech Main Business Overview
13.18.5 Shanghai Sunway Biotech Latest Developments
13.19 Changchun GeneScience Pharmaceutical
13.19.1 Changchun GeneScience Pharmaceutical Company Information
13.19.2 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.19.3 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Changchun GeneScience Pharmaceutical Main Business Overview
13.19.5 Changchun GeneScience Pharmaceutical Latest Developments
13.20 Harbin Pharmaceutical Group
13.20.1 Harbin Pharmaceutical Group Company Information
13.20.2 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.20.3 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Harbin Pharmaceutical Group Main Business Overview
13.20.5 Harbin Pharmaceutical Group Latest Developments
13.21 Hangzhou Jiuyuan Gene Engineering
13.21.1 Hangzhou Jiuyuan Gene Engineering Company Information
13.21.2 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.21.3 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview
13.21.5 Hangzhou Jiuyuan Gene Engineering Latest Developments
13.22 Kexing Biopharm
13.22.1 Kexing Biopharm Company Information
13.22.2 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.22.3 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Kexing Biopharm Main Business Overview
13.22.5 Kexing Biopharm Latest Developments
13.23 North China Pharmaceutical
13.23.1 North China Pharmaceutical Company Information
13.23.2 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.23.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 North China Pharmaceutical Main Business Overview
13.23.5 North China Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Granulocyte-Colony Stimulating Factor (G-CSF) by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Granulocyte-Colony Stimulating Factor (G-CSF) by Country/Region, 2021, 2025 & 2032
2.2 Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Type
2.2.1 Long-acting G-CSF
2.2.2 Short-acting G-CSF
2.2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type
2.2.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
2.2.3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Type (2021-2026)
2.3 Granulocyte-Colony Stimulating Factor (G-CSF) Segment by Application
2.3.1 Neutropenia
2.3.2 Other
2.3.3 Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application
2.3.3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Market Share by Application (2021-2026)
2.3.3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Breakdown Data by Company
3.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales by Company (2021-2026)
3.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Company (2021-2026)
3.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue by Company (2021-2026)
3.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Company (2021-2026)
3.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company (2021-2026)
3.3 Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Company
3.4 Key Manufacturers Granulocyte-Colony Stimulating Factor (G-CSF) Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Granulocyte-Colony Stimulating Factor (G-CSF) Product Location Distribution
3.4.2 Players Granulocyte-Colony Stimulating Factor (G-CSF) Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) BY GEOGRAPHIC REGION
4.1 World Historic Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Geographic Region (2021-2026)
4.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Granulocyte-Colony Stimulating Factor (G-CSF) Market Size by Country/Region (2021-2026)
4.2.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales by Country/Region (2021-2026)
4.2.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue by Country/Region (2021-2026)
4.3 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
4.4 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
4.5 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
4.6 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth
5 AMERICAS
5.1 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country
5.1.1 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
5.1.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026)
5.2 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
5.3 Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region
6.1.1 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026)
6.1.2 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2021-2026)
6.2 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
6.3 APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) by Country
7.1.1 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
7.1.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026)
7.2 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
7.3 Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) by Country
8.1.1 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026)
8.1.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026)
8.2 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026)
8.3 Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor (G-CSF)
10.3 Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor (G-CSF)
10.4 Industry Chain Structure of Granulocyte-Colony Stimulating Factor (G-CSF)
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Granulocyte-Colony Stimulating Factor (G-CSF) Distributors
11.3 Granulocyte-Colony Stimulating Factor (G-CSF) Customer
12 WORLD FORECAST REVIEW FOR GRANULOCYTE-COLONY STIMULATING FACTOR (G-CSF) BY GEOGRAPHIC REGION
12.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Market Size Forecast by Region
12.1.1 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecast by Region (2027-2032)
12.1.2 Global Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecast by Type (2027-2032)
12.7 Global Granulocyte-Colony Stimulating Factor (G-CSF) Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Amgen
13.1.1 Amgen Company Information
13.1.2 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.1.3 Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Amgen Main Business Overview
13.1.5 Amgen Latest Developments
13.2 Pfizer
13.2.1 Pfizer Company Information
13.2.2 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.2.3 Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Pfizer Main Business Overview
13.2.5 Pfizer Latest Developments
13.3 Chugai Pharmaceutical
13.3.1 Chugai Pharmaceutical Company Information
13.3.2 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.3.3 Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Chugai Pharmaceutical Main Business Overview
13.3.5 Chugai Pharmaceutical Latest Developments
13.4 Tanvex BioPharma
13.4.1 Tanvex BioPharma Company Information
13.4.2 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.4.3 Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Tanvex BioPharma Main Business Overview
13.4.5 Tanvex BioPharma Latest Developments
13.5 Kashiv BioSciences
13.5.1 Kashiv BioSciences Company Information
13.5.2 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.5.3 Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Kashiv BioSciences Main Business Overview
13.5.5 Kashiv BioSciences Latest Developments
13.6 Sandoz
13.6.1 Sandoz Company Information
13.6.2 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.6.3 Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sandoz Main Business Overview
13.6.5 Sandoz Latest Developments
13.7 Teva
13.7.1 Teva Company Information
13.7.2 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.7.3 Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Teva Main Business Overview
13.7.5 Teva Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.8.3 Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Coherus BioSciences
13.9.1 Coherus BioSciences Company Information
13.9.2 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.9.3 Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Coherus BioSciences Main Business Overview
13.9.5 Coherus BioSciences Latest Developments
13.10 Italfarmaco SpA
13.10.1 Italfarmaco SpA Company Information
13.10.2 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.10.3 Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Italfarmaco SpA Main Business Overview
13.10.5 Italfarmaco SpA Latest Developments
13.11 Evive Biotech
13.11.1 Evive Biotech Company Information
13.11.2 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.11.3 Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Evive Biotech Main Business Overview
13.11.5 Evive Biotech Latest Developments
13.12 Jiangsu Hengrui Pharmaceuticals
13.12.1 Jiangsu Hengrui Pharmaceuticals Company Information
13.12.2 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.12.3 Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Jiangsu Hengrui Pharmaceuticals Main Business Overview
13.12.5 Jiangsu Hengrui Pharmaceuticals Latest Developments
13.13 Amoytop Biotech
13.13.1 Amoytop Biotech Company Information
13.13.2 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.13.3 Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Amoytop Biotech Main Business Overview
13.13.5 Amoytop Biotech Latest Developments
13.14 Qilu Pharmaceutical
13.14.1 Qilu Pharmaceutical Company Information
13.14.2 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.14.3 Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Qilu Pharmaceutical Main Business Overview
13.14.5 Qilu Pharmaceutical Latest Developments
13.15 CSPC Baike Biopharma
13.15.1 CSPC Baike Biopharma Company Information
13.15.2 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.15.3 CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 CSPC Baike Biopharma Main Business Overview
13.15.5 CSPC Baike Biopharma Latest Developments
13.16 SL Pharm
13.16.1 SL Pharm Company Information
13.16.2 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.16.3 SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 SL Pharm Main Business Overview
13.16.5 SL Pharm Latest Developments
13.17 Lunan Pharmaceutical
13.17.1 Lunan Pharmaceutical Company Information
13.17.2 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.17.3 Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Lunan Pharmaceutical Main Business Overview
13.17.5 Lunan Pharmaceutical Latest Developments
13.18 Shanghai Sunway Biotech
13.18.1 Shanghai Sunway Biotech Company Information
13.18.2 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.18.3 Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Shanghai Sunway Biotech Main Business Overview
13.18.5 Shanghai Sunway Biotech Latest Developments
13.19 Changchun GeneScience Pharmaceutical
13.19.1 Changchun GeneScience Pharmaceutical Company Information
13.19.2 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.19.3 Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Changchun GeneScience Pharmaceutical Main Business Overview
13.19.5 Changchun GeneScience Pharmaceutical Latest Developments
13.20 Harbin Pharmaceutical Group
13.20.1 Harbin Pharmaceutical Group Company Information
13.20.2 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.20.3 Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Harbin Pharmaceutical Group Main Business Overview
13.20.5 Harbin Pharmaceutical Group Latest Developments
13.21 Hangzhou Jiuyuan Gene Engineering
13.21.1 Hangzhou Jiuyuan Gene Engineering Company Information
13.21.2 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.21.3 Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Hangzhou Jiuyuan Gene Engineering Main Business Overview
13.21.5 Hangzhou Jiuyuan Gene Engineering Latest Developments
13.22 Kexing Biopharm
13.22.1 Kexing Biopharm Company Information
13.22.2 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.22.3 Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Kexing Biopharm Main Business Overview
13.22.5 Kexing Biopharm Latest Developments
13.23 North China Pharmaceutical
13.23.1 North China Pharmaceutical Company Information
13.23.2 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
13.23.3 North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 North China Pharmaceutical Main Business Overview
13.23.5 North China Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-acting G-CSF
Table 4. Major Players of Short-acting G-CSF
Table 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2021-2026)
Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale by Application (2021-2026) & (K Units)
Table 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Market Share by Application (2021-2026)
Table 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application (2021-2026)
Table 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Company (2021-2026) & (K Units)
Table 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Company (2021-2026)
Table 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company (2021-2026)
Table 19. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Granulocyte-Colony Stimulating Factor (G-CSF) Producing Area Distribution and Sales Area
Table 21. Players Granulocyte-Colony Stimulating Factor (G-CSF) Products Offered
Table 22. Granulocyte-Colony Stimulating Factor (G-CSF) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026)
Table 35. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region (2021-2026)
Table 40. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 52. Key Market Challenges & Risks of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 53. Key Industry Trends of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 54. Granulocyte-Colony Stimulating Factor (G-CSF) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Granulocyte-Colony Stimulating Factor (G-CSF) Distributors List
Table 57. Granulocyte-Colony Stimulating Factor (G-CSF) Customer List
Table 58. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 74. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen Main Business
Table 76. Amgen Latest Developments
Table 77. Pfizer Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 79. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Chugai Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 83. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 84. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chugai Pharmaceutical Main Business
Table 86. Chugai Pharmaceutical Latest Developments
Table 87. Tanvex BioPharma Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 88. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 89. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Tanvex BioPharma Main Business
Table 91. Tanvex BioPharma Latest Developments
Table 92. Kashiv BioSciences Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 93. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 94. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Kashiv BioSciences Main Business
Table 96. Kashiv BioSciences Latest Developments
Table 97. Sandoz Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 98. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 99. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Sandoz Main Business
Table 101. Sandoz Latest Developments
Table 102. Teva Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 104. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Main Business
Table 106. Teva Latest Developments
Table 107. Mylan Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 109. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Mylan Main Business
Table 111. Mylan Latest Developments
Table 112. Coherus BioSciences Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 113. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 114. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Coherus BioSciences Main Business
Table 116. Coherus BioSciences Latest Developments
Table 117. Italfarmaco SpA Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 118. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 119. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Italfarmaco SpA Main Business
Table 121. Italfarmaco SpA Latest Developments
Table 122. Evive Biotech Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 123. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 124. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Evive Biotech Main Business
Table 126. Evive Biotech Latest Developments
Table 127. Jiangsu Hengrui Pharmaceuticals Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 129. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Jiangsu Hengrui Pharmaceuticals Main Business
Table 131. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 132. Amoytop Biotech Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 133. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 134. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Amoytop Biotech Main Business
Table 136. Amoytop Biotech Latest Developments
Table 137. Qilu Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 138. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 139. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Qilu Pharmaceutical Main Business
Table 141. Qilu Pharmaceutical Latest Developments
Table 142. CSPC Baike Biopharma Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 143. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 144. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. CSPC Baike Biopharma Main Business
Table 146. CSPC Baike Biopharma Latest Developments
Table 147. SL Pharm Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 148. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 149. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. SL Pharm Main Business
Table 151. SL Pharm Latest Developments
Table 152. Lunan Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 153. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 154. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Lunan Pharmaceutical Main Business
Table 156. Lunan Pharmaceutical Latest Developments
Table 157. Shanghai Sunway Biotech Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 158. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 159. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Shanghai Sunway Biotech Main Business
Table 161. Shanghai Sunway Biotech Latest Developments
Table 162. Changchun GeneScience Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 163. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 164. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Changchun GeneScience Pharmaceutical Main Business
Table 166. Changchun GeneScience Pharmaceutical Latest Developments
Table 167. Harbin Pharmaceutical Group Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 168. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 169. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Harbin Pharmaceutical Group Main Business
Table 171. Harbin Pharmaceutical Group Latest Developments
Table 172. Hangzhou Jiuyuan Gene Engineering Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 173. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 174. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Hangzhou Jiuyuan Gene Engineering Main Business
Table 176. Hangzhou Jiuyuan Gene Engineering Latest Developments
Table 177. Kexing Biopharm Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 178. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 179. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Kexing Biopharm Main Business
Table 181. Kexing Biopharm Latest Developments
Table 182. North China Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 183. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 184. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. North China Pharmaceutical Main Business
Table 186. North China Pharmaceutical Latest Developments
Table 1. Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Granulocyte-Colony Stimulating Factor (G-CSF) Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Long-acting G-CSF
Table 4. Major Players of Short-acting G-CSF
Table 5. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Table 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Type (2021-2026) & ($ million)
Table 8. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2021-2026)
Table 9. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale by Application (2021-2026) & (K Units)
Table 11. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Market Share by Application (2021-2026)
Table 12. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Application (2021-2026) & ($ million)
Table 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application (2021-2026)
Table 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Application (2021-2026) & (US$/Unit)
Table 15. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Company (2021-2026) & (K Units)
Table 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Company (2021-2026)
Table 17. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company (2021-2026)
Table 19. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Price by Company (2021-2026) & (US$/Unit)
Table 20. Key Manufacturers Granulocyte-Colony Stimulating Factor (G-CSF) Producing Area Distribution and Sales Area
Table 21. Players Granulocyte-Colony Stimulating Factor (G-CSF) Products Offered
Table 22. Granulocyte-Colony Stimulating Factor (G-CSF) Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Geographic Region (2021-2026) & (K Units)
Table 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Geographic Region (2021-2026)
Table 27. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country/Region (2021-2026) & (K Units)
Table 30. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country/Region (2021-2026)
Table 31. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (K Units)
Table 34. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026)
Table 35. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 37. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 38. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Region (2021-2026) & (K Units)
Table 39. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region (2021-2026)
Table 40. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 42. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 43. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (K Units)
Table 44. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 46. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 47. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Country (2021-2026) & (K Units)
Table 48. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Type (2021-2026) & (K Units)
Table 50. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Application (2021-2026) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 52. Key Market Challenges & Risks of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 53. Key Industry Trends of Granulocyte-Colony Stimulating Factor (G-CSF)
Table 54. Granulocyte-Colony Stimulating Factor (G-CSF) Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Granulocyte-Colony Stimulating Factor (G-CSF) Distributors List
Table 57. Granulocyte-Colony Stimulating Factor (G-CSF) Customer List
Table 58. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Region (2027-2032) & (K Units)
Table 59. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (K Units)
Table 61. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Region (2027-2032) & (K Units)
Table 63. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (K Units)
Table 65. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Type (2027-2032) & (K Units)
Table 69. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Forecast by Application (2027-2032) & (K Units)
Table 71. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Amgen Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 73. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 74. Amgen Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 75. Amgen Main Business
Table 76. Amgen Latest Developments
Table 77. Pfizer Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 78. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 79. Pfizer Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 80. Pfizer Main Business
Table 81. Pfizer Latest Developments
Table 82. Chugai Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 83. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 84. Chugai Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Chugai Pharmaceutical Main Business
Table 86. Chugai Pharmaceutical Latest Developments
Table 87. Tanvex BioPharma Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 88. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 89. Tanvex BioPharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 90. Tanvex BioPharma Main Business
Table 91. Tanvex BioPharma Latest Developments
Table 92. Kashiv BioSciences Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 93. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 94. Kashiv BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Kashiv BioSciences Main Business
Table 96. Kashiv BioSciences Latest Developments
Table 97. Sandoz Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 98. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 99. Sandoz Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Sandoz Main Business
Table 101. Sandoz Latest Developments
Table 102. Teva Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 104. Teva Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. Teva Main Business
Table 106. Teva Latest Developments
Table 107. Mylan Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 108. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 109. Mylan Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Mylan Main Business
Table 111. Mylan Latest Developments
Table 112. Coherus BioSciences Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 113. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 114. Coherus BioSciences Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Coherus BioSciences Main Business
Table 116. Coherus BioSciences Latest Developments
Table 117. Italfarmaco SpA Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 118. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 119. Italfarmaco SpA Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Italfarmaco SpA Main Business
Table 121. Italfarmaco SpA Latest Developments
Table 122. Evive Biotech Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 123. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 124. Evive Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Evive Biotech Main Business
Table 126. Evive Biotech Latest Developments
Table 127. Jiangsu Hengrui Pharmaceuticals Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 128. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 129. Jiangsu Hengrui Pharmaceuticals Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Jiangsu Hengrui Pharmaceuticals Main Business
Table 131. Jiangsu Hengrui Pharmaceuticals Latest Developments
Table 132. Amoytop Biotech Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 133. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 134. Amoytop Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Amoytop Biotech Main Business
Table 136. Amoytop Biotech Latest Developments
Table 137. Qilu Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 138. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 139. Qilu Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. Qilu Pharmaceutical Main Business
Table 141. Qilu Pharmaceutical Latest Developments
Table 142. CSPC Baike Biopharma Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 143. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 144. CSPC Baike Biopharma Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. CSPC Baike Biopharma Main Business
Table 146. CSPC Baike Biopharma Latest Developments
Table 147. SL Pharm Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 148. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 149. SL Pharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. SL Pharm Main Business
Table 151. SL Pharm Latest Developments
Table 152. Lunan Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 153. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 154. Lunan Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Lunan Pharmaceutical Main Business
Table 156. Lunan Pharmaceutical Latest Developments
Table 157. Shanghai Sunway Biotech Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 158. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 159. Shanghai Sunway Biotech Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Shanghai Sunway Biotech Main Business
Table 161. Shanghai Sunway Biotech Latest Developments
Table 162. Changchun GeneScience Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 163. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 164. Changchun GeneScience Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Changchun GeneScience Pharmaceutical Main Business
Table 166. Changchun GeneScience Pharmaceutical Latest Developments
Table 167. Harbin Pharmaceutical Group Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 168. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 169. Harbin Pharmaceutical Group Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Harbin Pharmaceutical Group Main Business
Table 171. Harbin Pharmaceutical Group Latest Developments
Table 172. Hangzhou Jiuyuan Gene Engineering Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 173. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 174. Hangzhou Jiuyuan Gene Engineering Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Hangzhou Jiuyuan Gene Engineering Main Business
Table 176. Hangzhou Jiuyuan Gene Engineering Latest Developments
Table 177. Kexing Biopharm Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 178. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 179. Kexing Biopharm Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Kexing Biopharm Main Business
Table 181. Kexing Biopharm Latest Developments
Table 182. North China Pharmaceutical Basic Information, Granulocyte-Colony Stimulating Factor (G-CSF) Manufacturing Base, Sales Area and Its Competitors
Table 183. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Product Portfolios and Specifications
Table 184. North China Pharmaceutical Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 185. North China Pharmaceutical Main Business
Table 186. North China Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 2. Granulocyte-Colony Stimulating Factor (G-CSF) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country/Region (2025)
Figure 10. Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-acting G-CSF
Figure 12. Product Picture of Short-acting G-CSF
Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type in 2026
Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2021-2026)
Figure 15. Granulocyte-Colony Stimulating Factor (G-CSF) Consumed in Neutropenia
Figure 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market: Neutropenia (2021-2026) & (K Units)
Figure 17. Granulocyte-Colony Stimulating Factor (G-CSF) Consumed in Other
Figure 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market: Other (2021-2026) & (K Units)
Figure 19. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Market Share by Application (2025)
Figure 20. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application in 2026
Figure 21. Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Company in 2026 (K Units)
Figure 22. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Company in 2026
Figure 23. Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Company in 2026 ($ millions)
Figure 24. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company in 2026
Figure 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 28. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 29. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 30. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 31. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 32. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 35. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country in 2026
Figure 36. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 38. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 39. United States Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region in 2026
Figure 44. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 46. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 47. China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country in 2026
Figure 55. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 57. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 58. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor (G-CSF) in 2026
Figure 72. Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 73. Industry Chain Structure of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 74. Channels of Distribution
Figure 75. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 2. Granulocyte-Colony Stimulating Factor (G-CSF) Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country/Region (2025)
Figure 10. Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Long-acting G-CSF
Figure 12. Product Picture of Short-acting G-CSF
Figure 13. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type in 2026
Figure 14. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Type (2021-2026)
Figure 15. Granulocyte-Colony Stimulating Factor (G-CSF) Consumed in Neutropenia
Figure 16. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market: Neutropenia (2021-2026) & (K Units)
Figure 17. Granulocyte-Colony Stimulating Factor (G-CSF) Consumed in Other
Figure 18. Global Granulocyte-Colony Stimulating Factor (G-CSF) Market: Other (2021-2026) & (K Units)
Figure 19. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sale Market Share by Application (2025)
Figure 20. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Application in 2026
Figure 21. Granulocyte-Colony Stimulating Factor (G-CSF) Sales by Company in 2026 (K Units)
Figure 22. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Company in 2026
Figure 23. Granulocyte-Colony Stimulating Factor (G-CSF) Revenue by Company in 2026 ($ millions)
Figure 24. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Company in 2026
Figure 25. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 28. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 29. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 30. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 31. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 32. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales 2021-2026 (K Units)
Figure 34. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue 2021-2026 ($ millions)
Figure 35. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country in 2026
Figure 36. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country (2021-2026)
Figure 37. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 38. Americas Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 39. United States Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Region in 2026
Figure 44. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Region (2021-2026)
Figure 45. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 46. APAC Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 47. China Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 51. India Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country in 2026
Figure 55. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share by Country (2021-2026)
Figure 56. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 57. Europe Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 58. Germany Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 59. France Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share by Application (2021-2026)
Figure 66. Egypt Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Granulocyte-Colony Stimulating Factor (G-CSF) in 2026
Figure 72. Manufacturing Process Analysis of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 73. Industry Chain Structure of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure 74. Channels of Distribution
Figure 75. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Forecast by Region (2027-2032)
Figure 76. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Granulocyte-Colony Stimulating Factor (G-CSF) Revenue Market Share Forecast by Application (2027-2032)
